Cerebral vasoreactivity in hypocapnia and hypercapnia in patients with diabetes mellitus type 2 with or without arterial hypertension;Reaktywnoość naczyń mózgowych w warunkach hipokapnii i hiperkapnii u chorych na cukrzycę typu 2 z nadciśnieniem tętniczym i bez nadciśnienia tętniczego

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 6, 2012, Pages 529-535

  Lasek Bal, Anetta ^a   Kazibutowska, Zofia ^a   Gołba, Anna ^a   Motta, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cerebral vasoreactivity; Diabetes mellitus; Hypercapnia; Hypocapnia

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CEREBRAL VASOREACTIVITY INDEX; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOCAPNIA; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSATILITY INDEX; RISK FACTOR;

EID: 84875155948     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.32175     Document Type: Article

References (27)

1. Dalal P., Parab P. Cerebrovascular disease in type 2 diabetes mellitus. Neurol India 2002; 50: 380-385.
2. Merimee T. Diabetic retinopathy. A synthesis and perspectives. New Engl J Med 1990; 322: 978.
3. Lippera S., Gregorio F., Ceravolo M. Diabetic retinopathy and cerebral hemodynamic impairment in type II diabetes. Eur J Ophthalmol 1997; 7: 156-162.
4. Paulson O., Strandgaard S., Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2: 161-192.
5. Shen J., Xue Y., Zhang Y., et al. The application of transcranial Doppler in detecting diabetic cerebral macroangiopathy and microangiopathy. Chinese J Int Med 2002; 41: 172-174.
6. Terborg Ch., Gora F., Weiller C. Reduced vasomotor reactivity in cerebral microangiopathy. A study with near-infrared spectroscopy and transcranial Doppler sonography. Stroke 2000; 31: 924-929.
7. Tatoñ J. Powikłania cukrzycy. Wydawnictwo Lekarskie PZWL, Warszawa 1995.
8. Grubb R.L., Derdeyn C.P., Fritsch S.M., et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 20: 246-350.
9. Gur A., Bova I., Bornstein N. Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke 1996; 27: 2188-2190.
10. Powers W. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991; 29: 231-240.
11. Ringelstein E.B., Weiller C., Weckesser M., et al. Cerebral vasomotor reactivity is significantly reduced in low-flow as compared to thromboembolic infarctions: the key role of thecircle of Willis. J Neurol Sci 1994; 121: 103-109.
12. Demchuk A., Christou J., Wein T. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000; 10: 1-2.
13. Demchuk A., Christou J., Wein T. Specific transcranial Doppler flow findings related to the presence and site arterial occlusion. Stroke 2000; 31: 140-146.
14. Kastrup A., Dichgans J., Niemeier M., et al. Changes of cerebro vascular CO2 reactivity during normal aging. Stroke 1998; 29: 1311-1314.
15. Markwalder T.M., Grolimund P., Seiler R.W., et al. De pen dency of blood flow velocity in the middle cerebral artery on end-tidal carbon dioxide partial pressure - a transcranial ultra sound Doppler study. J Cereb Blood Flow Metab 1984; 4: 368-372.
16. Panczel G., Bönöczk P., Voko Z., et al. Impaired vasoreactivity of the basilar artery system in patients with brainstem lacunar infarcts. Cerebrovasc Dis 1999; 9: 218-223.
17. Zimmermann C., Haberl R.L. L-arginine improves diminished cerebral CO2 reactivity in patients. Stroke 2003; 34: 643-647.
18. Lee K., Sohn Y., Baik J., et al. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke 2000; 31: 1111-1115.
19. Tkac I., Troscak M., Javorsky M., et al. Increased intracranial arterial resistance in patients with type 2 diabetes mellitus. Wien Klin Wochenschr 2001; 113: 870-873.
20. Yoon S., Zuccarello M., Rapoport R. Repeated constriction to respiration-induced hypocapnia is not mimicked by isocapnic alkaline solution in rabbit basilar artery in situ. Vascul Pharmacol 2003; 40: 7-11.
21. Kanno K., Hirata Y., Shichiri M., et al. Plasma endothelin 1 levels in patients with diabetes mellitus without vascular com plications. J Cardiovasc Pharmacol 1991; 17 (Suppl 7): 475-476.
22. Smulders R.A., Stehouwer C.D., Olthof C.G., et al. Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994; 87: 37-43.
23. Vazquez L.A., Amado J.A., Garcia-Unzueta M.T., et al. Decreased plasma endothelin-1 levels in asymptomatic type diabetic patients with regional cerebral hypoperfusion assessed by SPECT. J Diabetes Compl 1999; 13: 325-331.
24. Dandona P., James I.M., Newbury P., et al. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J 1978; 2: 325-326.
25. Fulesdi B., Limburg M., Bereczki D., et al. Impairment of cerebrovascular reactivity in long term type 1 diabetes. Diabetes 1997; 46: 1840-1845.
26. Tantucci C., Bottini P., Fiorani C., et al. Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. J Appl Physiol 2001; 90: 889-896.
27. Kozera G.M., Wolnik B., Kunicka K.B., et al. Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes. Diabetes Care 2009; 32: 878-882.